VictorMPriegoMD

PubMed

• Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
  Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, L...> ;The New England journal of medicine.
• Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
  Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, S...> ;The New England journal of medicine. 2020-09-19
• A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
  Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk V...> ;The New England journal of medicine. 2019-06-14
• 8 citations
  Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).
  John D. Hainsworth, David M. Waterhouse, Kent C. Shih, Ralph V. Boccia, Victor M. Priego, Michael McCleod, Fred J. Kudrik, Reed Brian Mitchell, Howard A. Burris, F. An...> ;Lung Cancer. 2018 Apr 1
• 17 citations
  TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
  Denise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky, David Drosick, Fred J. Kudrik, Linda D. Bosserman, Mark Keaton, Sharon A. Goble,...> ;Breast Cancer Research and Treatment. 2017 May 15
• 111 citations
  Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
  Adrian C. Newland, Bertrand Godeau, Victor M. Priego, Jean-François Viallard, Maria Fernanda Lopez Fernandez, Amelia Orejudos, Melissa Eisen> ;British Journal of Haematology. 2016 Jan 1
• 19 citations
  Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase...
  Denise A. Yardley, Linda D. Bosserman, Joyce O'Shaughnessy, William N. Harwin, Susan Kay Morgan, Victor M. Priego, N. W. Peacock, J. David Bass, Howard A. Burris, John...> ;Breast Cancer Research and Treatment. 2015 Oct 12
• 14 citations
  Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer
  Denise A. Yardley, Dianna Shipley, N. W. Peacock, Mythili Shastry, Rajiv Midha, Victor M. Priego, John D. Hainsworth> ;Breast Cancer Research and Treatment. 2015 Jul 9
• 1 citations
  Amrubicin as second- or third-line treatment for women with metastatic HER2-negative breast cancer: a Sarah Cannon Research Institute phase 1/2 trial
  Denise A. Yardley, Eric L. Raefsky, John D. Hainsworth, Howard A. Burris, Victor M. Priego, Alejandro A. Inclan> ;Breast Cancer Research and Treatment. 2014 Nov 6
• Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial.
  Jennings C, Kotseva K, De Bacquer D, Hoes A, de Velasco J, Brusaferro S, Mead A, Jones J, Tonstad S, Wood D, EUROACTION PLUS Study Group> ;European heart journal. 2014-03-09
• 105 citations
  Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
  John D. Hainsworth, Thomas J. Ervin, Elke K. Friedman, Victor M. Priego, Patrick B. Murphy, Bobby L. Clark, Ruth E. Lamar> ;Cancer. 2010 Aug 1
• Preliminary safety results from a multicenter phase II trial of nanoparticle albumin-bound paclitaxel/cyclophosphamide in early stage breast cancer plus trastuzumab in...
  Raefsky E, Inhorn R, Lange M, Peacock N, Shastry M, Vazquez E, Priego V, Franco L, Hainsworth JD, Yardley DA> ;J. Clin. Oncol.. 2009-05-20
• 7 citations
  A Phase I trial of spirogermanium administered on a continuous infusion schedule.
  Paul V. Woolley, James D. Ahlgren, Patrick J. Byrne, Victor M. Priego, Philip S. Schein> ;Investigational New Drugs. 1984 Jan 1
• 14 citations
  Methotrexate-induced immune haemolytic anaemia.
  Paul V. Woolley, Ronald A. Sacher, Victor M. Priego, Moses S. Schanfield, Eric M. Bonnem> ;British Journal of Haematology. 1983 Aug 1
• Join now to see all